https://scholars.lib.ntu.edu.tw/handle/123456789/590531
標題: | Epidemiology, diagnosis and management of intracranial atherosclerotic disease | 作者: | JIANN-SHING JENG SUNG-CHUN TANG HON-MAN LIU |
公開日期: | 2010 | 卷: | 8 | 期: | 10 | 起(迄)頁: | 1423-1432 | 來源出版物: | Expert Review of Cardiovascular Therapy | 摘要: | Intracranial atherosclerotic disease (ICAD) is a major cause of ischemic stroke, with higher occurrence rates in Asian, black and Hispanic individuals than in white individuals. Important risk factors for ICAD include age, hypertension, diabetes mellitus and metabolic syndrome. ICAD patients have a 10-20% annual risk of stroke, with greater risk in patients with high-grade stenosis (70-99%). Given the high risk of stroke recurrence in symptomatic ICAD patients, effective secondary prevention strategies are needed. Currently, there is no strong evidence supporting the use of anticoagulants in ICAD patients; antiplatelet drugs are still the preferred medication. Recently, angioplasty and stenting for ICAD has emerged as an alternative approach to medical treatment, owing to high technical success rates and low risk of periprocedural complications. However, the rate of in-stent restenosis is moderate, and the long-term benefit of endovascular treatment is not well established. High-quality randomized trials comparing angioplasty/stenting with the best medical therapy in ICAD patients are anticipated. ? 2010 Expert Reviews Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958100730&doi=10.1586%2ferc.10.129&partnerID=40&md5=a46c6eaa82f07e1acb67257f2934972e https://scholars.lib.ntu.edu.tw/handle/123456789/590531 |
ISSN: | 14779072 | DOI: | 10.1586/erc.10.129 | SDG/關鍵字: | acetylsalicylic acid; anticoagulant agent; antithrombocytic agent; cilostazol; clopidogrel; placebo; warfarin; add on therapy; angioplasty; bleeding; cardiovascular risk; cerebrovascular disease; clinical trial; diabetes mellitus; digital subtraction angiography; drug fatality; human; hypertension; intracranial atherosclerotic disease; metabolic syndrome X; outcome assessment; prevalence; radiodiagnosis; review; stent; stroke; treatment failure; treatment outcome; Age Factors; Angioplasty; Humans; Intracranial Arteriosclerosis; Platelet Aggregation Inhibitors; Postoperative Complications; Recurrence; Risk Factors; Stents; Stroke |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。